Ompi expands its EZ-fill Syringes offer by adding up an Integrated Safety System (ISS) for staked needle syringes to prevent end users’ injury
The EZ-fill ISS is a new fully passive safety system designed to guarantee end users’ safety and reduce total cost of ownership for the pharmaceutical companies.
it is the first development within the platform licensed by Tip-Top, a primary designer of proprietary safety needlestick protection devices and technologies.
Based on their mini-Max design, Ompi EZ-fill ISS avoids piercing after rubber needle shield removal, providing an end-user experience similar to a standard syringe.
“In addition to end users’ safety and intuitive use, it enables the pharmaceutical company to maintain the glass primary container of choice,” said Andrea Zambon, Marketing Director Pharmaceutical Systems division at Stevanato Group.
“Ompi EZ-fill ISS is designed to fit the existing fill-finish formats. It is supplied in a standard nest and tub configuration for easy processing on current fill-finish lines, with a significant reduction in terms of total cost of ownership.”
The Integrated Safety System is the result of a rubber needle shield inserted in a plastic shield with flexible wings, combined with a ring and a hub, pre-assembled on the Ompi EZ-fill Syringe.
Its functional performances allow locking the needle inside the safety device with no possibility to expose it again after usage.
Ompi EZ-fill Integrated Safety System (ISS) has been developed for all formats of staked needle syringes and it is customisable in needle gauge and length, barrel volume, ISO standard rubber components and siliconisation. It meets the needs of biotech, heparin and vaccine applications.